Tobacco Research and Treatment Center, Division of General Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Diabetes Care. 2011 Oct;34(10):2250-5. doi: 10.2337/dc11-0710. Epub 2011 Aug 11.
Whether nicotine leads to a persistent increase in blood glucose levels is not clear. Our objective was to assess the relationship between cotinine, a nicotine metabolite, and glycated hemoglobin (HbA(1c)), an index of recent glycemia.
We used cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2008. We limited our analysis to 17,287 adults without diabetes. We created three cotinine categories: <0.05 ng/mL, 0.05-2.99 ng/mL, and ≥3 ng/mL.
Using self-report, 25% of the sample were current smokers, 24% were former smokers, and 51% were nonsmokers. Smokers had a higher mean HbA(1c) (5.36% ± 0.01 SE) compared with never smokers (5.31% ± 0.01) and former smokers (5.31% ± 0.01). In a similar manner, mean HbA(1c) was higher among participants with cotinine ≥3 ng/mL (5.35% ± 0.01) and participants with cotinine 0.05-2.99 ng/mL (5.34% ± 0.01) compared with participants with cotinine <0.05 ng/mL (5.29% ± 0.01). In multivariable-adjusted analysis, we found that both a cotinine ≥3 ng/mL and self-reported smoking were associated with higher HbA(1c) compared with a cotinine <0.05 ng/mL or not smoking. People with a cotinine level ≥3 ng/mL had a relative 5% increase in HbA(1c) compared with people with a cotinine level <0.05 ng/mL, and smokers had a relative 7% increase in HbA(1c) compared with never smokers.
Our study suggests that cotinine is associated with increased HbA(1c) in a representative sample of the U.S. population without diabetes.
尼古丁是否会导致血糖持续升高尚不清楚。我们的目的是评估可替宁(一种尼古丁代谢物)与糖化血红蛋白(HbA(1c))之间的关系,后者是近期血糖水平的指标。
我们使用了 1999 年至 2008 年全国健康和营养调查(NHANES)的横断面数据。我们将分析仅限于 17287 名无糖尿病的成年人。我们创建了三个可替宁类别:<0.05ng/ml、0.05-2.99ng/ml 和≥3ng/ml。
使用自我报告,样本中有 25%为当前吸烟者,24%为曾经吸烟者,51%为非吸烟者。吸烟者的平均 HbA(1c)(5.36%±0.01 SE)高于从不吸烟者(5.31%±0.01)和曾经吸烟者(5.31%±0.01)。同样,可替宁≥3ng/ml(5.35%±0.01)和可替宁 0.05-2.99ng/ml(5.34%±0.01)的参与者的平均 HbA(1c)高于可替宁<0.05ng/ml(5.29%±0.01)的参与者。在多变量调整分析中,我们发现,与可替宁<0.05ng/ml 或不吸烟相比,可替宁≥3ng/ml 以及自我报告的吸烟均与 HbA(1c)升高相关。与可替宁水平<0.05ng/ml 的人相比,可替宁水平≥3ng/ml 的人 HbA(1c)相对增加了 5%,与从不吸烟者相比,吸烟者 HbA(1c)相对增加了 7%。
我们的研究表明,在没有糖尿病的美国代表性人群中,可替宁与 HbA(1c)升高有关。